Zydus Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Acyclovir Sodium Injection, 50 mg/mL Due to Crystallization


Pennington, NJ, Zydus Pharmaceuticals (USA) Inc. is voluntarily recalling four lots of Acyclovir Sodium Injection, 50 mg/mL, 10 mL and 20 mL vials, to the Hospital/User level after receiving several complaints of crystallization in vials. Administration of crystalized Acyclovir Sodium Injection, 50 (US Food Recalls) More More

Similar stories

Crystallization Complaints Prompt Recall of Injectable Antiviral - Monthly Prescribing Reference

Crystallization Complaints Prompt Recall of Injectable Antiviral  Monthly Prescribing Reference

Posted on 30 March 2021 | 2:00 am | Google News

Recon: Pfizer begins pediatric trial of COVID vaccine; AstraZeneca revises vaccine efficacy rate to 76% - Regulatory Focus

Recon: Pfizer begins pediatric trial of COVID vaccine; AstraZeneca revises vaccine efficacy rate to 76%  Regulatory Focus

Posted on 25 March 2021 | 2:00 am | Google News

Zydus Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Acyclovir Sodium Injection, 50 mg/mL Due to Crystallization - FDA.gov

Zydus Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Acyclovir Sodium Injection, 50 mg/mL Due to Crystallization  FDA.gov

Posted on 24 March 2021 | 2:00 am | Google News

Copyright © 2021 LastMinuteStuff.com | Contact info